Controlled Trial Evaluating the Efficacy of Protein Supplementation in the Short Term After Bariatric Surgery
PROTISLEEVE
Randomized Controlled Trial Prospective Single-center Open Evaluating the Efficacy of Supplementation (Adapted to the Post-operative Period) Current Protein After Bariatric Surgery Like Sleeve Gastrectomy
2 other identifiers
interventional
90
1 country
1
Brief Summary
The main objective will be to evaluate the effect at 5 weeks of nutritional management associated with protein supplementation (adapted to the post-operative period) on the maintenance of lean body mass at the whole body in obese patients after a sleeve gastrectomy. Secondary objectives will assess protein intake, food safety, the effect of protein supplementation on body fat in the entire body and the metabolic rate and the impact on quality of life and post-operative joint pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Oct 2016
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2016
CompletedFirst Posted
Study publicly available on registry
March 17, 2016
CompletedStudy Start
First participant enrolled
October 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2023
CompletedApril 2, 2025
March 1, 2025
7 years
March 14, 2016
March 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in lean mass (kg) will be assessed at the level of whole-body dual-energy X-ray absorptiometry (DXA)
up to 1 month
Secondary Outcomes (5)
food diary
5 weeks after the hospital discharge
change rate IGF1, IGFBP3
up to 1 month
the quality of life
up to 1 month
the quality of life
up to 5 years
change rate IGF1, IGFBP3
up to 5 years
Study Arms (2)
usual dietary management
NO INTERVENTIONControl group: usual dietary management Following the intervention, the stomach of patients underwent many changes
care of with usual dietary protein supplementation
EXPERIMENTALIntervention group: Usual dietary management with protein supplementation (30g) in addition to the usual inputs
Interventions
Protein supplementation : Protein intake of 30 grams of protein in addition to the usual inputs (to the recommended amounts of 60 to 120 g per day), upon the resumption of oral intake until the fifth week after sleeve gastrectomy.
Eligibility Criteria
You may qualify if:
- surgical management of sleeve gastrectomy kind
You may not qualify if:
- food allergies
- Weight\> 135 kg (maximum weight supported by the DXA)
- orthopedic prosthesis (hip, knee ...) that would make it impossible to interpret the measurement of DXA
- History of bariatric surgery: adjustable gastric banding, vertical banded gastrectomy ...
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UHMontpellier
Montpellier, 34295, France
Related Publications (2)
Maimoun L, Aouinti S, Puech M, Lefebvre P, Deloze M, de Santa Barbara P, Renard E, Christol JP, Myzia J, Picot MC, Mariano-Goulart D, Nocca D. Changes in Lean Tissue Mass, Fat Mass, Biological Parameters and Resting Energy Expenditure over 24 Months Following Sleeve Gastrectomy. Nutrients. 2023 Feb 27;15(5):1201. doi: 10.3390/nu15051201.
PMID: 36904198RESULTMaimoun L, Aouinti S, Puech M, Lefebvre P, Humbert L, Deloze M, de Santa Barbara P, Maimoun-Nande L, Boudousq V, Cristol JP, Renard E, Picot MC, Mariano-Goulart D, Nocca D. Modification of bone architecture following sleeve gastrectomy: a five-year follow-up. J Bone Miner Res. 2025 Feb 2;40(2):251-261. doi: 10.1093/jbmr/zjae202.
PMID: 39693376RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David NOCCA
University Hospital, Montpellier
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2016
First Posted
March 17, 2016
Study Start
October 19, 2016
Primary Completion
October 30, 2023
Study Completion
October 30, 2023
Last Updated
April 2, 2025
Record last verified: 2025-03